Literature DB >> 21353224

Haptoglobin genotype and the iron hypothesis of atherosclerosis.

Hilla Lee Viener1, Andrew P Levy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21353224      PMCID： PMC3089707          DOI： 10.1016/j.atherosclerosis.2011.01.029

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  23 in total

1.  Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study.

Authors:  Andrew P Levy; Irit Hochberg; Kathleen Jablonski; Helaine E Resnick; Elisa T Lee; Lyle Best; Barbara V Howard
Journal:  J Am Coll Cardiol       Date:  2002-12-04       Impact factor: 24.094

2.  Association of haptoglobin genotype and common cardiovascular risk factors with the amount of iron in atherosclerotic carotid plaques.

Authors:  Christos Lioupis; Calypso Barbatis; Aggeliki Drougou; Vasiliki Koliaraki; Avgi Mamalaki; Christos Klonaris; Sotirios Georgopoulos; Vasilios Andrikopoulos; Elias Bastounis
Journal:  Atherosclerosis       Date:  2011-01-26       Impact factor: 5.162

3.  Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction.

Authors:  Mahmoud Suleiman; Doron Aronson; Rabea Asleh; Michael R Kapeliovich; Ariel Roguin; Simcha R Meisel; Michael Shochat; Abeer Sulieman; Shimon A Reisner; Walter Markiewicz; Haim Hammerman; Rachel Lotan; Nina S Levy; Andrew P Levy
Journal:  Diabetes       Date:  2005-09       Impact factor: 9.461

4.  Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype.

Authors:  Shany Blum; Moshe Vardi; Jonathan B Brown; Allen Russell; Uzi Milman; Chen Shapira; Nina S Levy; Rachel Miller-Lotan; Rabea Asleh; Andrew P Levy
Journal:  Pharmacogenomics       Date:  2010-05       Impact factor: 2.533

5.  Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial.

Authors:  Uzi Milman; Shany Blum; Chen Shapira; Doron Aronson; Rachel Miller-Lotan; Yefim Anbinder; Junia Alshiek; Lawrence Bennett; Maria Kostenko; Michele Landau; Shlomo Keidar; Yishai Levy; Alexander Khemlin; Arman Radan; Andrew P Levy
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-11-21       Impact factor: 8.311

6.  Haptoglobin genotype is predictive of major adverse cardiac events in the 1-year period after percutaneous transluminal coronary angioplasty in individuals with diabetes.

Authors:  Ariel Roguin; Werner Koch; Adnan Kastrati; Doron Aronson; Albert Schomig; Andrew P Levy
Journal:  Diabetes Care       Date:  2003-09       Impact factor: 19.112

Review 7.  Iron in arterial plaque: modifiable risk factor for atherosclerosis.

Authors:  Jerome L Sullivan
Journal:  Biochim Biophys Acta       Date:  2008-06-19

Review 8.  Haptoglobin: basic and clinical aspects.

Authors:  Andrew P Levy; Rabea Asleh; Shany Blum; Nina S Levy; Rachel Miller-Lotan; Shiri Kalet-Litman; Yefim Anbinder; Orit Lache; Farid M Nakhoul; Roy Asaf; Dan Farbstein; Mordechai Pollak; Yitzhak Z Soloveichik; Merav Strauss; Jonia Alshiek; Alina Livshits; Avery Schwartz; Hoda Awad; Kheir Jad; Hagit Goldenstein
Journal:  Antioxid Redox Signal       Date:  2010-02       Impact factor: 8.401

9.  Pharmacogenomic application of the haptoglobin genotype in the treatment of HDL dysfunction.

Authors:  Avery Schwartz; Shany Blum; Rabea Asleh; Mordechai Pollak; Shiri Kalet-Litman; Andrew P Levy
Journal:  Pharmgenomics Pers Med       Date:  2009-02-27

10.  Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype.

Authors:  Rabea Asleh; Shany Blum; Shiri Kalet-Litman; Jonia Alshiek; Rachel Miller-Lotan; Roy Asaf; Wasseem Rock; Michael Aviram; Uzi Milman; Chen Shapira; Zaid Abassi; Andrew P Levy
Journal:  Diabetes       Date:  2008-07-03       Impact factor: 9.461
View more
  2 in total

Review 1.  Acute phase reactants as novel predictors of cardiovascular disease.

Authors:  M S Ahmed; A B Jadhav; A Hassan; Qing H Meng
Journal:  ISRN Inflamm       Date:  2012-05-06

2.  Haptoglobin 2-2 Phenotype Is Associated With Increased Acute Kidney Injury After Elective Cardiac Surgery in Patients With Diabetes Mellitus.

Authors:  Chenzhuo Feng; Bhiken I Naik; Wenjun Xin; Jennie Z Ma; David C Scalzo; Swapna Thammishetti; Robert H Thiele; Zhiyi Zuo; Jacob Raphael
Journal:  J Am Heart Assoc       Date:  2017-10-05       Impact factor: 5.501
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.